Clinical Trials

257 enrolled

Breast Neoplasms

NCT02278120 2024-03-12

MONALEESA-7

672 enrolled 16 charts 1 FDA

Advanced Metastatic Breast Cancer

NCT02333370 2023-06-08

A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Phase 1 Completed

88 enrolled

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

NCT02753686 2023-02-15

Treat ER+ight

Completed

440 enrolled

Endocrine

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT01393990 2020-03-24

A Study of LY2228820 in Participants With Advanced Cancer

Phase 1 Completed

89 enrolled 30 charts

Advanced Cancer

NCT02093351 2019-10-02

To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer

Phase 1 Completed

79 enrolled 35 charts

Tumor-Agnostic

Neoplasms

NCT02970682 2019-07-12

STEM

60 enrolled

Breast Neoplasms

NCT00728949 2018-06-06

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

93 enrolled 14 charts

Breast Neoplasms

NCT00847366 2018-03-15

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

Phase NA Completed

10 enrolled

BreastSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma

NCT00171704 2017-03-03

A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

263 enrolled 12 charts

Breast Neoplasms

NCT00036270 2015-10-28

TEAM

9,779 enrolled 13 charts

Breast Neoplasms

NCT00229697 2015-10-05

Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

317 enrolled

Breast Neoplasms

NCT00038467 2014-05-07

IES

4,740 enrolled 31 charts

Breast Neoplasms

NCT00537771 2013-01-25

HEART

Phase 4 Completed

384 enrolled 9 charts

Breast Neoplasms

NCT00605267 2012-09-06

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

197 enrolled 23 charts

Breast Neoplasms, Neoplasms

NCT00241449 2012-06-06

A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

51 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00279448 2011-12-23

TEAM

9,779 enrolled

Breast Neoplasms

NCT00152178 2011-07-07

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

680 enrolled

Breast Neoplasms

NCT00233610 2011-01-27

Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer

180 enrolled

Genitourinary

Prostatic Neoplasms

NCT00232661 2010-02-03

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

452 enrolled

Breast Neoplasms

NCT00287534 2009-06-09

ARNO-95

1,059 enrolled

Breast Neoplasms

NCT00784862 2009-05-15

ATAC - Pharmacokinetics (PK) Sub-Protocol

9,358 enrolled

Breast Neoplasms

NCT00286117 2009-05-01

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

448 enrolled

Breast Neoplasms

NCT00784680 2009-05-01

ATAC - Quality of Life Sub-Protocol

308 enrolled

Quality of Life

NCT00814125 2009-05-01

ATAC - Endometrial Sub-Protocol

285 enrolled

Breast Neoplasms

NCT00784940 2009-04-27

ATAC - Bone Density Sub-Protocol

308 enrolled

Bone Density

NCT00034125 2006-07-19

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.